We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $8.21B
1-Year Est. Return 28.81%
This Fund
S&P 500
This Quarter Est. Return
+4.84%
1 Year Est. Return
+28.81%
3 Year Est. Return
+92.54%
5 Year Est. Return
+114.67%
10 Year Est. Return
+429.8%
AUM
$3.43B
AUM Growth
+$75.3M
Cap. Flow
-$42M
Cap. Flow %
-1.22%
Top 10 Hldgs %
13.83%
Holding
1,352
New
131
Increased
487
Reduced
534
Closed
83

Top Sells

Rank Stock Value
1
GE icon
GE Aerospace
GE
+$9.73M
2
MSFT icon
Microsoft
MSFT
+$6.54M
3
LMT icon
Lockheed Martin
LMT
+$5.54M
4
DD icon
DuPont de Nemours
DD
+$5.19M
5
AAPL icon
Apple
AAPL
+$4.57M

Sector Composition

Rank Sector Weight
1 Healthcare 14.45%
2 Technology 10.24%
3 Financials 10.23%
4 Industrials 9%
5 Consumer Discretionary 8.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BNY
526
Bank of New York Mellon
BNY
$108B
$1.19M 0.03%
29,707
-7,595
-20% -$303K
XLE icon
527
State Street Energy Select Sector SPDR ETF
XLE
$39.5B
$1.17M 0.03%
33,158
-26,802
-45% -$918K
IFV icon
528
First Trust Dorsey Wright International Focus 5 ETF
IFV
$226M
$1.17M 0.03%
66,704
+49,422
+286% +$859K
BT
529
DELISTED
BT Group plc (ADR)
BT
$1.17M 0.03%
+45,828
New +$1.2M
AJG icon
530
Arthur J. Gallagher & Co
AJG
$63.7B
$1.16M 0.03%
22,852
+925
+4% +$45.7K
MTRN icon
531
Materion
MTRN
$5.01B
$1.16M 0.03%
37,750
HQH
532
abrdn Healthcare Investors
HQH
$1.23B
$1.15M 0.03%
48,419
+1,601
+3% +$40.3K
ABB
533
DELISTED
ABB Ltd
ABB
$1.15M 0.03%
50,995
-4,022
-7% -$86.2K
EQT icon
534
EQT Corp
EQT
$33.2B
$1.15M 0.03%
29,025
DTE icon
535
DTE Energy
DTE
$31.1B
$1.15M 0.03%
14,371
-656
-4% -$53.5K
NS
536
DELISTED
NuStar Energy L.P.
NS
$1.15M 0.03%
23,083
-22
-0.1% -$1.06K
BLV icon
537
Vanguard Long-Term Bond ETF
BLV
$5.75B
$1.14M 0.03%
11,588
+33
+0.3% +$3.27K
VIAB
538
DELISTED
Viacom Inc. Class B
VIAB
$1.14M 0.03%
29,910
+13,309
+80% +$552K
AYI icon
539
Acuity Brands
AYI
$9.88B
$1.14M 0.03%
4,298
-719
-14% -$191K
FXH icon
540
First Trust Health Care AlphaDEX Fund
FXH
$1.02B
$1.14M 0.03%
18,653
-1,667
-8% -$101K
CCI icon
541
Crown Castle
CCI
$32.7B
$1.13M 0.03%
12,020
-543
-4% -$52.2K
BPL
542
DELISTED
Buckeye Partners, L.P.
BPL
$1.13M 0.03%
15,757
+10,071
+177% +$717K
IVE icon
543
iShares S&P 500 Value ETF
IVE
$48.9B
$1.13M 0.03%
11,867
-234
-2% -$22.3K
FIT
544
DELISTED
Fitbit, Inc. Class A common stock
FIT
$1.13M 0.03%
75,876
+8,377
+12% +$122K
UTF icon
545
Cohen & Steers Infrastructure Fund
UTF
$3.14B
$1.12M 0.03%
51,937
+6,620
+15% +$142K
ELME
546
Elme Communities
ELME
$132M
$1.12M 0.03%
35,937
CINF icon
547
Cincinnati Financial
CINF
$28.3B
$1.11M 0.03%
14,743
+147
+1% +$11.1K
CF icon
548
CF Industries
CF
$19.2B
$1.1M 0.03%
45,109
-31,081
-41% -$759K
AME icon
549
Ametek
AME
$55.5B
$1.09M 0.03%
22,800
PCG icon
550
PG&E
PCG
$47.8B
$1.09M 0.03%
17,768
-13,256
-43% -$842K

Similar funds

Oppenheimer & Co's Q3 2016 Portfolio in Review

As of Q3 2016, Oppenheimer & Co held 1,352 positions worth $3.43B, up 2.2% from $3.35B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Oppenheimer & Co's Q3 2016 filing shows 131 new, 487 increased, 534 reduced and 83 closed positions. Its largest new stake was Brookfield Infrastructure Partners: 168,877 shares worth $3.48M. The largest sale was GE Aerospace, an estimated $9.73M.

By sector, the portfolio is most concentrated in Healthcare at 14% of assets, down from 15% a quarter earlier, followed by Technology and Financials.

  • Oppenheimer & Co's largest Q3 2016 buy was Brookfield Infrastructure Partners: 168,877 shares worth $3.48M.
  • Oppenheimer & Co added most to Bristol-Myers Squibb in Q3 2016, an estimated $6.72M increase.
  • Oppenheimer & Co's biggest Q3 2016 reduction was GE Aerospace, cutting an estimated $9.73M.
  • Oppenheimer & Co fully exited Agrium in Q3 2016, selling an estimated $3.32M.
  • Oppenheimer & Co's ten largest holdings make up 14% of its $3.43B portfolio in Q3 2016.
  • Oppenheimer & Co opened 131 new positions and closed 83 in Q3 2016.
  • Oppenheimer & Co's portfolio value rose 2.2% quarter-over-quarter to $3.43B.

Based on Oppenheimer & Co's 13F filing for Q3 2016, filed 7 Nov 2016.